Article Details

MorphoSys' Licensing Partner Roche Received Breakthrough Therapy Designation for ...

Retrieved on: 2021-10-11 06:45:00

Tags for this article:

Click the tags to see associated articles and topics

MorphoSys' Licensing Partner Roche Received Breakthrough Therapy Designation for .... View article details on hiswai:

Excerpt

Roche is evaluating the safety and efficacy of gantenerumab in these two pivotal trials with more than 2,000 participants for more than two years. The trials ...

Article found on: uk.sports.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up